Clinical trial
A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients…
NCT00432562 · Mast Therapeutics, Inc., Industry · Completed
Key facts
| NCT number | NCT00432562 |
|---|---|
| Title | A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer. |
| Official title | A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion (ANX-530) in Patients With Advanced Cancer. |
| Lead sponsor | Mast Therapeutics, Inc., Industry |
| Collaborators | Synteract, Inc. Industry Thywill Latam Solutions SRL OCASA Soluciones Logísticas S.A. Worldwide Clinical Trials |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer, Non-small Cell Lung Cancer, Non-Hodgkins Lymphoma |
| Intervention type | Drug |
| Interventions | Vinorelbine Tartrate |
| Enrollment | 31 |
| Start date | Feb 1, 2007 |
| Primary completion | Nov 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Feb 8, 2007 |
| Last update posted | Feb 23, 2012 |
| Countries | Argentina |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: